Shizuoka, Japan

Satoshi Yaginuma


Average Co-Inventor Count = 4.9

ph-index = 6

Forward Citations = 76(Granted Patents)


Location History:

  • Yokka, JP (1988)
  • Shizuoka, JP (1981 - 1992)

Company Filing History:


Years Active: 1981-1992

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Satoshi Yaginuma: Innovator in Aldose Reductase Inhibitors

Introduction

Satoshi Yaginuma is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of aldose reductase inhibitors. With a total of 10 patents to his name, Yaginuma's work has the potential to impact the treatment of diabetic complications.

Latest Patents

Yaginuma's latest patents include innovative compounds designed to inhibit aldose reductase. One notable patent describes an aldose reductase inhibitor comprising a compound of a specific formula, where R is lower alkyl or cyclohexylmethyl, and n is 2 or 3. These compounds exhibit superior aldose reductase inhibiting activity with high stability, making them useful for preventing and treating diabetic complications. Another patent focuses on biphenyl-5,5'-bis-alkanoic acid derivatives, which also serve as aldose reductase inhibitors. These compounds are characterized by their effective components and potential therapeutic applications.

Career Highlights

Throughout his career, Yaginuma has worked with notable companies such as Toyo Jozo Kabushiki Kaisha and Toyo Jozo Company, Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Yaginuma has collaborated with esteemed colleagues, including Akira Asahi and Naoki Muto. These partnerships have likely enhanced his research and development efforts in the field of aldose reductase inhibitors.

Conclusion

Satoshi Yaginuma is a distinguished inventor whose work in aldose reductase inhibitors holds promise for advancing diabetes treatment. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…